COMBINATION THERAPY FOR COPD

• 收藏
• 分享

专利权人:

CHIESI FARMACEUTICI S.P.A.

发明人:

BONELLI,SAURO,USBERTI,FRANCESCA,ZAMBELLI,ENRICO

申请号：

MYPI 2012002844

公开号：

MY156949A

申请日:

2010.12.22

申请国别(地区):

MY

年份:

2016

代理人:

摘要：

THE INVENTION CONCERNS AN AEROSOL FORMULATION SUITABLE FOR ADMINISTERING TO COPD PATIENTS BY MEANS OF A PRESSURIZED METERED DOSE INHALER (PMDI), COMPRISING GLYCOPYRRONIUM BROMIDE IN COMBINATION WITH FORMOTEROL. THE FORMULATION FURTHER COMPRISES A HFA PROPELLANT, A CO-SOLVENT, AND AN AMOUNT OF INORGANIC ACID SUFFICIENT TO STABILIZE BOTH THE GLYCOPYRRONIUM BROMIDE AND THE FORMOTEROL COMPONENTS. OPTIONALLY THE FORMULATION FURTHER COMPRISES BECLOMETASONE DIPROPIONATE.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/